Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Optimism in inclusion body myositis: a double-blind randomised controlled phase III trial investigating the effect of sirolimus on disease progression in patients with IBM as measured by the IBM Functional Rating Scale
Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands.;Murdoch Univ, Ctr Mol Med & Innovat Therapeut, Murdoch, WA, Australia..
Royal Brisbane & Womens Hosp, Dept Neurol, Brisbane 4029, Australia.;Univ Queensland, Ctr Clin Res, Brisbane, Australia.;Murdoch Univ, Ctr Mol Med & Innovat Therapeut, Murdoch, WA, Australia..
Univ Sydney, Brain & Mind Ctr, Camperdown, NSW, Australia.;Murdoch Univ, Ctr Mol Med & Innovat Therapeut, Murdoch, WA, Australia.;Affin Clin Res, Nedlands, WA, Australia..
Concord Repatriat Gen Hosp, Dept Neurol, Concord, NSW, Australia.;Murdoch Univ, Ctr Mol Med & Innovat Therapeut, Murdoch, WA, Australia..
Show others and affiliations
2025 (English)In: Clinical and Experimental Rheumatology, ISSN 0392-856X, E-ISSN 1593-098X, Vol. 43, no 2, p. 316-325Article in journal (Refereed) Published
Abstract [en]

OBJECTIVES:Inclusion body myositis (IBM) is a complex inflammatory muscle disease in adults over 40, with histological features of autoinflammation, cell stress and autophagic abnormalities, and marked clinically by relentless progression with no effective disease-modifying therapy. Sirolimus (rapamycin) may help maintain function by inhibiting T effector cells, preserving T regulatory cells, inducing autophagy, and improving mitochondrial function. This international trial follows a phase II pilot study.

METHODS:This phase IIb/III double-blind, randomised, controlled trial (RCT) of sirolimus involves 140 IBM patients randomly assigned with equal allocation to sirolimus (2 mg) or matching placebo. This RCT aims to assess the efficacy of sirolimus compared to placebo in slowing or stabilising IBM progression, as measured by the mean change in patient function using the IBM Functional Rating Scale (IBM-FRS) from Baseline to Week 84. Secondary outcomes will evaluate efficacy and safety to inform future clinical trial design.

RESULTS:Ethical approval has been granted in Australia (St Vincent’s Hospital Melbourne HREC-D 311/20) and the USA (University of Kansas Medical Center Human Research Protection Program FWA no. 00003411), with European approval pending. The protocol is version 3.0 (02-Dec-2022). Trial registration: ANZCTR: ACTRN12620001226998p, ClinicalTrials.gov: NCT04789070, UTN: U1111-1258-1354, and EU CT 2024-514575-17-00.

CONCLUSIONS:This phase IIb/III trial builds on prior findings to assess sirolimus’s potential in slowing or halting IBM progression, preserving patient function and independence, and advancing IBM therapeutic strategies and trial design.

Place, publisher, year, edition, pages
Clinical and Experimental Rheumatology , 2025. Vol. 43, no 2, p. 316-325
Keywords [en]
clinical trials, inclusion body myositis, international, investigator-inititated
National Category
Neurology Endocrinology and Diabetes Neurosciences
Identifiers
URN: urn:nbn:se:uu:diva-552574DOI: 10.55563/clinexprheumatol/zvffa0ISI: 001434979200002PubMedID: 40018746OAI: oai:DiVA.org:uu-552574DiVA, id: diva2:1958275
Available from: 2025-05-14 Created: 2025-05-14 Last updated: 2025-05-14Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records

Leonard, Dag

Search in DiVA

By author/editor
Leonard, Dag
By organisation
Rheumatology
In the same journal
Clinical and Experimental Rheumatology
NeurologyEndocrinology and DiabetesNeurosciences

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 238 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf